Gene · 3148
Papers1,965
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,965
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Furanocoumarins as Enhancers of Antitumor Potential of Sorafenib and LY294002 toward Human Glioma Cells In Vitro. | Int J Mol Sci | 2024 | 38255833 | PubTator, text mining | PubMed |
| Blocking the E2F transcription factor 1/high-mobility group box 2 pathway enhances the intervention effects of α-santalol on the malignant behaviors of liver cancer cells. | Int J Biochem Cell Biol | 2024 | 38219975 | PubTator, text mining | PubMed |
| Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. | Nat Immunol | 2024 | 38212464 | PubTator, text mining | PubMed |
| Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and potential drug targets in hepatocellular carcinoma. | Cancer Cell Int | 2024 | 38178084 | PubTator, text mining | PubMed |
| Identification of aging-related genes in diagnosing osteoarthritis via integrating bioinformatics analysis and machine learning. | Aging (Albany NY) | 2024 | 38175691 | PubTator, text mining | PubMed |
| Ionizing radiation induces vascular smooth muscle cell senescence through activating NF-κB/CTCF/p16 pathway. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38141838 | PubTator, text mining | PubMed |
| Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function. | Stem Cell Reports | 2024 | 38101398 | PubTator, text mining | PubMed |
| Therapeutic potential of natural antisense transcripts and various mechanisms involved for clinical applications and disease prevention. | RNA Biol | 2024 | 38090817 | PubTator, text mining | PubMed |
| Cell cycle-dependent gene networks for cell proliferation activated by nuclear CK2α complexes. | Life Sci Alliance | 2024 | 37907238 | PubTator, text mining | PubMed |
| FSHD muscle shows perturbation in fibroadipogenic progenitor cells, mitochondrial function and alternative splicing independently of inflammation. | Hum Mol Genet | 2024 | 37856562 | PubTator, text mining | PubMed |
| Crosstalk among T cells, epithelial cells, and fibroblasts identifies a prognostic signature in oral squamous cell carcinoma. | Oral Dis | 2024 | 37491735 | PubTator, text mining | PubMed |
| HMGA2 promotes nasopharyngeal carcinoma progression and is associated with tumor resistance and poor prognosis. | Front Oncol | 2023 | 38304037 | PubTator, text mining | PubMed |
| Application progress of single-cell sequencing technology in mesenchymal stem cells research. | Front Cell Dev Biol | 2023 | 38264356 | PubTator, text mining | PubMed |
| Antitumor Immunity: Role of NK Cells and Extracellular Vesicles in Cancer Immunotherapy. | Curr Issues Mol Biol | 2023 | 38248313 | PubTator, text mining | PubMed |
| Immunoregulatory functions and therapeutic potential of natural killer cell-derived extracellular vesicles in chronic diseases. | Front Immunol | 2023 | 38239346 | PubTator, text mining | PubMed |
| Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia. | bioRxiv | 2023 | 38234720 | PubTator, text mining | PubMed |
| The apoptotic and anti-proliferative effect of Lysyl oxidase propeptide in Y79 human retinoblastoma cells. | Mol Vis | 2023 | 38222455 | PubTator, text mining | PubMed |
| Exploring HMGB2 in hepatocellular carcinoma: charting new paths for diagnostic and therapeutic innovations. | J Gastrointest Oncol | 2023 | 38196529 | PubTator, text mining | PubMed |
| Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. | Front Oncol | 2023 | 38169859 | PubTator, text mining | PubMed |
| Canonical IRE1 function needed to sustain vigorous natural killer cell proliferation during viral infection. | iScience | 2023 | 38162021 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3148/papers?page=8